Cargando…

Serum progesterone levels greater than 32.5 ng/ml on the day of embryo transfer are associated with lower live birth rate after artificial endometrial preparation: a prospective study

BACKGROUND: Previous observational studies have highlighted the negative effects of serum hormone levels at the minimum threshold during frozen embryo transfer (FET) cycles. However, still the questions regarding the maximum threshold level, and the highest allowed dosage of hormonal medications rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alyasin, Ashraf, Agha-Hosseini, Marzieh, Kabirinasab, Motahareh, Saeidi, Hojatollah, Nashtaei, Maryam Shabani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890906/ https://www.ncbi.nlm.nih.gov/pubmed/33602270 http://dx.doi.org/10.1186/s12958-021-00703-6

Ejemplares similares

Natural cycle versus artificial cycle in frozen-thawed embryo transfer: A randomized prospective trial
por: Agha-Hosseini, Marzieh, et al.
Publicado: (2018)

Reviewers BJCVS 32.5
Publicado: (2017)

Early Progesterone Change Associated With Pregnancy Outcome After Fresh Embryo Transfer in Assisted Reproduction Technology Cycles With Progesterone Level of >1.5 ng/ml on Human Chorionic Gonadotropin Trigger Day
por: Lee, Chun-I, et al.
Publicado: (2020)

Growth Hormone (GH) Improvement of Ovarian Responses and Pregnancy Outcome in Poor Ovarian Responders: A Randomized Study
por: Safdarian, Leyli, et al.
Publicado: (2019)

The effect of intrauterine hCG injection before embryo transfer on pregnancy rate in frozen embryo transfer cycles()()
por: Jahanshahi, Moghadaseh, et al.
Publicado: (2022)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

AB013. The study on the diagnostic value of f/tPSA to the prostate cancer with tPSA greater than 10 ng/mL
por: Li, Yan-Feng, et al.
Publicado: (2016)

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0 ng/mL to 13.0 ng/mL
por: Singh, Gurmukh, et al.
Publicado: (2015)

Combining clinical parameters and multiparametric magnetic resonance imaging to stratify biopsy-naïve men for an optimum diagnostic strategy with prostate-specific antigen 4 ng ml(−1) to 10 ng ml(−1)
por: Zhang, Chi-Chen, et al.
Publicado: (2022)

The E$_{c.m.}$ = 32.5 MeV resonance in $^{12}$C + $^{12}$C
por: Freeman, R M, et al.
Publicado: (1995)

Exploring parallel MPI fault tolerance mechanisms for phylogenetic inference with RAxML-NG
por: Hübner, Lukas, et al.
Publicado: (2021)

Effect of Sulphur-Containing Tailings Content and Curing Temperature on the Properties of M32.5 Cement Mortar
por: Chen, Qian, et al.
Publicado: (2021)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

Endometrial progesterone resistance and PCOS
por: Li, Xin, et al.
Publicado: (2014)

Effects of clomiphene citrate plus estradiol or progesterone on endometrial ultrastructure: An RCT
por: Taheripanah, Robabeh, et al.
Publicado: (2020)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml(-1) and 10.1–20.0 ng ml(-1): a multicenter study
por: Lin, Yu-Rong, et al.
Publicado: (2015)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
por: Johnson, Michael H., et al.
Publicado: (2015)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
por: Shaida, Nadeem, et al.
Publicado: (2009)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
por: Kan, Hung-Cheng, et al.
Publicado: (2017)

RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference
por: Kozlov, Alexey M, et al.
Publicado: (2019)

Adaptive RAxML-NG: Accelerating Phylogenetic Inference under Maximum Likelihood using Dataset Difficulty
por: Togkousidis, Anastasis, et al.
Publicado: (2023)

Health Tract No. 325: The Ego
Publicado: (1868)

Progesterone Signaling in Endometrial Epithelial Organoids
por: Hewitt, Sylvia C., et al.
Publicado: (2022)

Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
por: Ahn, Jae Hyun, et al.
Publicado: (2014)

Correlation of Serum Androgens and Pituitary Hormone Levels with Serum PSA Less Than 2.5 NG/ML
por: Sofikerim, Mustafa, et al.
Publicado: (2007)

Multivariate Regression Analysis Identifying Predictors of Patient Satisfaction with Multifocal IOLs: +4.00/+4.00 vs +3.25/+3.25 vs +3.25/EDOF
por: Bucci, Frank A
Publicado: (2020)

Geometry of the Muon Storage Ring 325
por: Verdier, A
Publicado: (2000)

On the Proton-Bound Noble Gas Dimers (Ng-H-Ng)(+) and (Ng-H-Ng’)(+) (Ng, Ng’ = He-Xe): Relationships between Structure, Stability, and Bonding Character
por: Borocci, Stefano, et al.
Publicado: (2021)

Endometrial gene expression reveals compromised progesterone signaling in women refractory to embryo implantation
por: Tapia-Pizarro, Alejandro, et al.
Publicado: (2014)

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL
por: Iwamoto, Hiroaki, et al.
Publicado: (2019)

Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
por: Wu, Qiang, et al.
Publicado: (2021)

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
por: Solomonidou, Nantia, et al.
Publicado: (2023)

Excitation functions of inelastic and transfer channels in $^{12}C + ^{12}C$ around $E_{c.m.}$ = 32.5 MeV
por: Szilner, S, et al.
Publicado: (1996)

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml
por: Kim, Hyoung Woo, et al.
Publicado: (2011)

Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA
por: Zhao, Jing, et al.
Publicado: (2016)

OR16-6 Cardiometabolic Abnormalities in Patients with Acromegaly with Elevated Plasma IGF-1 Concentrations but GH Concentrations <2ng/ml
por: Hannon, Anne Marie, et al.
Publicado: (2019)

Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
por: Chung, Jae Hoon, et al.
Publicado: (2020)

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
por: Liang, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8b0qq6uufs3ngk1s4rtct5ndc5